
Darrell H S Tan
Researcher
2
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
Aug 24, 2026
ENCORE: Updated HIV prophylaxis guidelines: what clinicians need to know
11:07
11:15
11:24
11:45
11:54
B
10:57Blair BighamHOST
So where aren't we seeing uptake? What populations deserve sort of that equity focus at this point in time?

Darrell TanGUEST
I mean, in the HIV epidemic, we know that, uh, we always wanna be thinking about some of the key populations that have borne a disproportionate burden.

Darrell TanGUEST
And largely in Canada since the beginning of the epidemic, roughly half of the epidemic has occurred among gay, bisexual, other men who have sex with men.

Darrell TanGUEST
However, within that group, there are actually many folks who are doing as a population or as a group actually fairly well in terms of PrEP uptake, and we see disproportionately low uptake among sexual minority men who may face intersecting identities that have been historically underrepresented.

Darrell TanGUEST
So, for example, racialized GBM, gay, bisexual, other men who have sex with men, Black, Indigenous, two-spirit individuals are over-represented.

Darrell TanGUEST
And then when we think about other populations aside from sexual minority men, as we mentioned a moment ago, Indigenous populations in some parts of the country, again, it's quite varied, right? There's many, many Indigenous identities and communities across this huge land, of course.
B
15:50Blair BighamHOST
How can a physician walk through the risk assessment with a patient to determine if a strong recommendation should be made from our side of the table, as opposed to someone coming to us sort of self-identifying the risk?
This new drug could be a game-changer for HIV/AIDS
5:35
5:42
5:51

Darrell TanGUEST
Their job is to carefully review the science, critically review every piece of documentation that they're provided by, uh, a drug company.

Darrell TanGUEST
I think Canadians should be, um, pleased that we have a, a rigorous review process.

Darrell TanGUEST
Maybe that happens to some extent, but I think it's a matter of, uh, Health Canada doing a s- a, a careful and thorough job at, at ensuring that a drug they are gonna say and ratify, you know, this, a, a, a, deserves regulatory approval because it's safe enough and effective enough for our populations.
6 MINS LATER